News & Events News Back December 10, 2020 Salarius Pharmaceuticals Receives First Installment of $1.7 Million in Payments from the Cancer Prevention and Research Institute of Texas Contact Tiberend Strategic Advisors, Inc. Johanna Bennett jbennett@tiberend.com Download PDF